Results 241 to 250 of about 2,066,293 (312)

Combined 5‐aminolevulinic acid and ferric ammonium citrate treatment promotes hair follicle growth by activating dermal papilla cells

FEBS Open Bio, EarlyView.
5‐Aminolevulinic acid combined with ferric ammonium citrate (5‐ALA/FAC) stimulates dermal papilla cell activity and promotes hair follicle growth. The treatment enhances ERK and AKT signaling, increases hair‐inductive gene expression, and restores dermal papilla function suppressed by dihydrotestosterone and oxidative stress, resulting in enhanced hair
Han‐Wook Ryu, Eok‐Soo Oh, Sewoon Kim
wiley   +1 more source

Beyond the algorithm: why oncology nursing in Asia-Pacific needs evidence-based AI evaluation. [PDF]

Asia Pac J Oncol Nurs
Adapa K, Kotte S, Metta M, Escobar-Agreda S, Sethi R, Patil G, Mazur L.   +6 more
europepmc   +1 more source

Blood‐based proteomic profiling reveals context‐dependent changes in BCL2‐associated signaling during taxane therapy in breast cancer patients

FEBS Open Bio, EarlyView.
Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani, Eiman Y. Ibrahim, Rozalyn L. Rodwin, Leah M. Ferrucci, Kim Blenman, Maryam Lustberg, Barbara E. Ehrlich   +6 more
wiley   +1 more source

Access to innovation in oncology from patients' perspectives: a qualitative systematic review. [PDF]

EClinicalMedicine
Julliot-Delval A, Teixeira M, Cartron E.
europepmc   +1 more source

Author Correction: A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities. [PDF]

Nat Commun
Yang Z, Wei S, Duan H, Wang X, Zhang D, Kiang KM, Deng Y, Yang Y, Ku Y, Hu W, Zou C, Tang M, Jiang Y, Liu Y, Lan H, Chen Z, Leung GK, Jia W, Mou Y, Liu L, Zhang G.   +20 more
europepmc   +1 more source

Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors. [PDF]

Eur Urol Open Sci
Mandel P, Wenzel M, Chun F, Graefen M, Gandur Quiroga MN, Rodriguez-Vida A, Bourlon MT, Myint ZW, Bernal L, Ürün Y, Kopp RM, Juan Fita MJ, Zapata Laguado MI, Büttner T, Fiala O, Fujita K, Li H, Kopecky J, Matrana MR, Bögemann M, Carrozza F, Zgura A, Buchler T, Matthews D, Yazgan SC, Lenci E, Ansari J, Marques Monteiro FS, Soares A, Rizzo A, Ciccimarra F, Massari F, Jazieh AR, Santoni M.   +33 more
europepmc   +1 more source

When herds overgraze: the cost of conformity in oncology drug development. [PDF]

BMJ Oncol
Liu J, LoRusso P.
europepmc   +1 more source

Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort study. [PDF]

Clin Transl Radiat Oncol
Deijen CL, Berbée M, Geijsen ED, Neelis KJ, Wee L, Bakker-Van der Jagt MAB, Boer AH, Ceha HM, Cnossen JS, Intven MPW, Leseman-Hoogenboom MM, Mulder-Ebrahimi G, Muller K, Oppedijk V, Reerink O, Rütten H, Spruit PH, van Triest B, LPRGE Dutch Platform for Radiotherapy in Gastro-Enterology.   +18 more
europepmc   +1 more source

Correction to “Altered splicing of ATG16‐L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non‐small cell lung cancer”

Molecular Oncology, EarlyView.
wiley   +1 more source

Correction to “Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability”

Molecular Oncology, EarlyView.
wiley   +1 more source